MicroRNAs (MiRNAs) that targeted ADP-ribosylation factor 6 (ARF6) were predicted and selected in high metastatic breast cancer cells treated with C–C motif chemokine ligand 18 (CCL18).
[Molecular Therapy Oncolytics]
Sorry, but the selected Zotpress account can't be found.